I notice they are going after HER2 positive tumors.http://www.sciencedaily.com/releases/2012/08/120815093108.htmglta
but does the timing add up since beginning of trials?
Just ask Anna!JMHO
Sure looks like what we are doing. I cant wait till we show awesome survial extensions with grn163l or grn 1005. Steve
No need for 1005.Geron has nothing left!JMHO